Related references
Note: Only part of the references are listed.Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase-2 inhibitor and toceranib phosphate
Daniel Alonso-Miguel et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2022)
Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats
Amy K. LeBlanc et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2021)
Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs
Stanislav Pantelyushin et al.
CANCERS (2021)
From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review
Guillermo Valdivia et al.
FRONTIERS IN VETERINARY SCIENCE (2021)
PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma
Naoya Maekawa et al.
NPJ PRECISION ONCOLOGY (2021)
Cowpea mosaic virus stimulates antitumor immunity through recognition by multiple MYD88-dependent toll-like receptors
Chenkai Mao et al.
BIOMATERIALS (2021)
Simple and effective bacterial-based intratumoral cancer immunotherapy
Christina S. E. Carroll et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients
Oluwadamilola M. Fayanju et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors
Kurt A. Schalper et al.
NATURE MEDICINE (2020)
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe C. Yuen et al.
NATURE MEDICINE (2020)
OMIP-065: Dog Immunophenotyping and T-Cell Activity Evaluation with a 14-Color Panel
Stanislav Pantelyushin et al.
CYTOMETRY PART A (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs
Masaya Igase et al.
SCIENTIFIC REPORTS (2020)
Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
Amber Kerstetter-Fogle et al.
CANCERS (2019)
Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
Hui Cai et al.
ADVANCED SCIENCE (2019)
The use of low-dose metronomic chemotherapy in dogsinsight into a modern cancer field
T. B. Gaspar et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation
P. Jack Hoopes et al.
MOLECULAR PHARMACEUTICS (2018)
The impact of toceranib, piroxicam and thalidomide with or without hypofractionated radiation therapy on clinical outcome in dogs with inflammatory mammary carcinoma
F. Rossi et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
Willi Sauerbrei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Inflammatory breast cancer biology: the tumour microenvironment is key
Bora Lim et al.
NATURE REVIEWS CANCER (2018)
Immune regulation of canine tumour and macrophage PD-L1 expression
G. Hartley et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
Comparative aspects of canine and human inflammatory breast cancer
Teresa P. Raposo et al.
SEMINARS IN ONCOLOGY (2017)
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors
Kurt W. Evans et al.
CLINICAL CANCER RESEARCH (2017)
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Carlos Alfaro et al.
CANCER TREATMENT REVIEWS (2017)
Inflammatory breast cancer in the Netherlands; improved survival over the last decades
D. J. P. van Uden et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer
P. H. Lizotte et al.
NATURE NANOTECHNOLOGY (2016)
Incidence of mammary tumors in the canine population living in the Veneto region (Northeastern Italy): Risk factors and similarities to human breast cancer
Marta Vascellari et al.
PREVENTIVE VETERINARY MEDICINE (2016)
Comparative oncology: what dogs and other species can teach us about humans with cancer
Joshua D. Schiffman et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes
Priscilla F. McAuliffe et al.
PLOS ONE (2015)
Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem
Yaritza Salas et al.
PLOS ONE (2015)
Incidence of Inflammatory Breast Cancer in Women, 1992-2009, United States
Bryan Goldner et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Modeling and characterization of inflammatory breast cancer emboli grown in vitro
Heather L. Lehman et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Systematic Review of Nonsteroidal Anti-Inflammatory Drug-Induced Adverse Effects in Dogs
B. P. Monteiro-Steagall et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2013)
Clinical and Immunomodulatory Effects of Toceranib Combined with Low-Dose Cyclophosphamide in Dogs with Cancer
L. Mitchell et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2012)
Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias
Gabriela Bottaro Gelaleti et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Low-Dose Cyclophosphamide Selectively Decreases Regulatory T Cells and Inhibits Angiogenesis in Dogs with Soft Tissue Sarcoma
J. H. Burton et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2011)
Development of a questionnaire assessing health-related quality-of-life in dogs and cats with cancer
S. Lynch et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2011)
Decreased Ratio of CD8+ T Cells to Regulatory T Cells Associated with Decreased Survival in Dogs with Osteosarcoma
B. J. Biller et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2010)
Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008)
Laura Marconato et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2009)
Changes in Regulatory T Cells in Dogs with Cancer and Associations with Tumor Type
K. O'Neill et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2009)
Survival time of dogs with inflammatory/mammary cancer treated with palliative therapy alone or palliative therapy plus chemotherapy
M. Clemente et al.
VETERINARY RECORD (2009)
Trends in inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute
KW Hance et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Toll-like receptor pathways in the immune responses to mycobacteria
V Quesniaux et al.
MICROBES AND INFECTION (2004)
Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy
JA Low et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Canine inflammatory mammary carcinoma:: histopathology, immunohistochemistry and clinical implications of 21 cases
L Peña et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma
ML Alpaugh et al.
ONCOGENE (2002)
Share Paper
